Related references
Note: Only part of the references are listed.Terminal Interface Conformations Modulate Dimer Stability Prior to Amino Terminal Autoprocessing of HIV-1 Protease
Johnson Agniswamy et al.
BIOCHEMISTRY (2012)
HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural Rearrangements
Johnson Agniswamy et al.
BIOCHEMISTRY (2012)
Context Surrounding Processing Sites Is Crucial in Determining Cleavage Rate of a Subset of Processing Sites in HIV-1 Gag and Gag-Pro-Pol Polyprotein Precursors by Viral Protease
Sook-Kyung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Choreography of HIV-1 Proteolytic Processing and Virion Assembly
Sook-Kyung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1
Manabu Aoki et al.
JOURNAL OF VIROLOGY (2012)
Placement of Leucine Zipper Motifs at the Carboxyl Terminus of HIV-1 Protease Significantly Reduces Virion Production
Yen-Yu Pan et al.
PLOS ONE (2012)
Kinetic characterization of the critical step in HIV-1 protease maturation
S. Kashif Sadiq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Modelling dynamics in protein crystal structures by ensemble refinement
B. Tom Burnley et al.
ELIFE (2012)
A Cleavage Enzyme-Cytometric Bead Array Provides Biochemical Profiling of Resistance Mutations in HIV-1 Gag and Protease
Sebastian Breuer et al.
BIOCHEMISTRY (2011)
Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
Yasuhiro Koh et al.
JOURNAL OF VIROLOGY (2011)
Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors
John M. Louis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions
Liangqun Huang et al.
RETROVIROLOGY (2011)
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
Annemarie M. J. Wensing et al.
ANTIVIRAL RESEARCH (2010)
Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries
Max W. Chang et al.
BIOCHEMICAL JOURNAL (2010)
The Initial Step in Human Immunodeficiency Virus Type 1 GagProPol Processing Can Be Regulated by Reversible Oxidation
Sarah I. Daniels et al.
PLOS ONE (2010)
Conformational stability of pGEX-expressed Schistosoma japonicum glutathione S-transferase: A detoxification enzyme and fusion-protein affinity tag
Warren Kaplan et al.
PROTEIN SCIENCE (2010)
Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease
Rieko Ishima et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing
Liangqun Huang et al.
RETROVIROLOGY (2010)
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat
Catherine S. Adamson et al.
RETROVIROLOGY (2010)
Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells
Liangqun Huang et al.
AIDS RESEARCH AND THERAPY (2010)
Analysis and characterization of dimerization inhibition of a multi-drug-resistant Human Immunodeficiency Virus Type 1 protease using a novel size-exclusion chromatographic approach
David A. Davis et al.
BIOCHEMICAL JOURNAL (2009)
Monomer-Dimer Equilibrium in Glutathione Transferases: A Critical Re-Examination
Raffaele Fabrini et al.
BIOCHEMISTRY (2009)
Modulation of Human Immunodeficiency Virus Type 1 Protease Autoprocessing by Charge Properties of Surface Residue 69
Liangqun Huang et al.
JOURNAL OF VIROLOGY (2009)
Uncoupling Human Immunodeficiency Virus Type 1 gag and pol Reading Frames: Role of the Transframe Protein p6*in Viral Replication
Andreas Leiherer et al.
JOURNAL OF VIROLOGY (2009)
Relating sequence evolution of HIV1-protease to its underlying molecular mechanics
K. Hamacher
GENE (2008)
Catalytically Active Monomer of Glutathione S-Transferase π and Key Residues Involved in the Electrostatic Interaction between Subunits
Yu-chu Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease
Jane M. Sayer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A new homogeneous assay for high throughput serological diagnosis of brucellosis in ruminants
John A. McGiven et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6*for spatiotemporal regulation of protease activation
Christine Ludwig et al.
JOURNAL OF VIROLOGY (2008)
Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease
Chun Tang et al.
NATURE (2008)
Novel macromolecular inhibitors of human immunodeficiency virus-1 protease
Gabriella Miklossy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization
Yasuhiro Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Conformational flexibility in the flap domains of ligand-free HIV protease
Holly Heaslet et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor
Rieko Ishima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface
L. Bannwarth et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism
Monique Nijhuis et al.
PLOS MEDICINE (2007)
Aspartic proteases in drug discovery
Joerg Eder et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Host factors exploited by retroviruses
Stephen P. Goff
NATURE REVIEWS MICROBIOLOGY (2007)
Human immunodeficiency virus type I resistance to the small molecule maturation inhibitor 3-O-(3′,3′-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in gag
Jing Zhou et al.
JOURNAL OF VIROLOGY (2006)
Opportunities for structure-based design of protease-directed drugs
Peer R. E. Mittl et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
David A. Davis et al.
ANTIVIRAL RESEARCH (2006)
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate
M Prabu-Jeyabalan et al.
JOURNAL OF VIROLOGY (2006)
Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1
D Dulude et al.
VIROLOGY (2006)
Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: A single mode of inhibition for the three HIV enzymes ?
Maria-Jose Camarasa et al.
ANTIVIRAL RESEARCH (2006)
Tipranavir - A novel nonpeptidic protease inhibitor of HIV
Jennifer R. King et al.
CLINICAL PHARMACOKINETICS (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates
SC Pettit et al.
RETROVIROLOGY (2005)
Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 Å resolution crystal structures of HIV-1 protease mutants with substrate analogs
YF Tie et al.
FEBS JOURNAL (2005)
Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease
SC Pettit et al.
JOURNAL OF VIROLOGY (2005)
Folding regulates autoprocessing of HIV-1 protease precursor
A Chatterjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains
YF Tie et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-131) is dispensable for the virus in vitro
G Bleiber et al.
JOURNAL OF GENERAL VIROLOGY (2004)
HIV-1 and the host cell: an intimate association
EO Freed
TRENDS IN MICROBIOLOGY (2004)
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism
SC Pettit et al.
JOURNAL OF VIROLOGY (2004)
Contribution of the Gag-Pol transframe domain p6*and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1
C Paulus et al.
VIROLOGY (2004)
Retrovirus budding
E Morita et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
F Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Solution structure of the mature HIV-1 protease monomer - Insight into the tertiary fold and stability of a precursor
R Ishima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of RNA elements that regulate Gag-Pol ribosomal frameshifting in equine infectious anemia virus
CP Chen et al.
JOURNAL OF VIROLOGY (2003)
Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation
DA Davis et al.
JOURNAL OF VIROLOGY (2003)
The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage
SC Pettit et al.
JOURNAL OF VIROLOGY (2003)
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease
SC Pettit et al.
JOURNAL OF VIROLOGY (2002)
Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites
A Fehér et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Folded monomer of HIV-1 protease
R Ishima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Proteolytic processing of the P2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation
M Shehu-Xhilaga et al.
JOURNAL OF VIROLOGY (2001)
Macromolecular inhibitors of HIV-1 protease - Characterization of designed heterodimers
JE Rozzelle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structural and biochemical studies of retroviral proteases
A Wlodawer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Share Paper
